These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26405628)

  • 1. Socioeconomic status and incidence of breast cancer by hormone receptor subtype.
    Akinyemiju TF; Pisu M; Waterbor JW; Altekruse SF
    Springerplus; 2015; 4():508. PubMed ID: 26405628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).
    Sineshaw HM; Gaudet M; Ward EM; Flanders WD; Desantis C; Lin CC; Jemal A
    Breast Cancer Res Treat; 2014 Jun; 145(3):753-63. PubMed ID: 24794028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 status and disparities in luminal breast cancers.
    Holowatyj AN; Ruterbusch JJ; Ratnam M; Gorski DH; Cote ML
    Cancer Med; 2016 Aug; 5(8):2109-16. PubMed ID: 27250116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
    Parise C; Caggiano V
    J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.
    Parise CA; Caggiano V
    J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women.
    Linnenbringer E; Geronimus AT; Davis KL; Bound J; Ellis L; Gomez SL
    Breast Cancer Res Treat; 2020 Apr; 180(2):437-447. PubMed ID: 32002766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California.
    Aoki RF; Uong SP; Gomez SL; Alexeeff SE; Caan BJ; Kushi LH; Torres JM; Guan A; Canchola AJ; Morey BN; Lin K; Kroenke CH
    Cancer; 2021 Dec; 127(24):4602-4612. PubMed ID: 34415571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
    Zhang W; Bai Y; Sun C; Lv Z; Wang S
    Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.
    Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E
    J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes.
    Parise CA; Caggiano V
    Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic disparities and breast cancer hormone receptor status.
    Andaya AA; Enewold L; Horner MJ; Jatoi I; Shriver CD; Zhu K
    Cancer Causes Control; 2012 Jun; 23(6):951-8. PubMed ID: 22527173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
    Van Asten K; Slembrouck L; Olbrecht S; Jongen L; Brouckaert O; Wildiers H; Floris G; Van Limbergen E; Weltens C; Smeets A; Paridaens R; Giobbie-Hurder A; Regan MM; Viale G; Thürlimann B; Vergote I; Christodoulou E; Van Calster B; Neven P
    Oncologist; 2019 Feb; 24(2):165-171. PubMed ID: 30171067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity.
    Huang HC; Smart MH; Zolekar A; Deng H; Hubbard CC; Hoskins KF; Ko NY; Guadamuz JS; Calip GS
    Breast Cancer Res Treat; 2022 Jun; 193(3):707-716. PubMed ID: 35460499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.